Zhiqiang Bai

Intelligent stretching of ankle joints with contracture/spasticity.

Biomechanic changes in passive properties of hemiplegic ankles with spastic hypertonia.

Aging-related neuromuscular changes characterized by tendon reflex system properties.

Serum proteomics with SELDI-TOF-MS in congenital human cytomegalovirus hepatitis.

Separate quantification of reflex and nonreflex components of spastic hypertonia in chronic hemiparesis.

Effect of inducible expressed human cytomegalovirus immediate early 86 protein on cell apoptosis.

Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.

MicroRNAs control herpesviral dormancy.

A MACHINE LEARNING APPROACH FOR miRNA TARGET PREDICTION.

Inhibition of human cytomegalovirus infection by IE86-specific short hairpin RNA-mediated RNA interference.

Regulation of herpesvirus lifecycle by viral microRNAs.

A cluster of transcripts encoded by KSHV ORF30-33 gene locus.

A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.

Development and strategies of VEGFR-2/KDR inhibitors.

HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway.

Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.

Genomewide mapping and screening of Kaposi's sarcoma-associated herpesvirus (KSHV) 3' untranslated regions identify bicistronic and polycistronic viral transcripts as frequent targets of KSHV microRNAs.

KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways.

Effects of matrine on the proliferation and apoptosis of human medulloblastoma cell line D341.

De Novo Reconstruction of Adipose Tissue Transcriptomes Reveals Long Non-coding RNA Regulators of Brown Adipocyte Development.

A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling.